Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
Nucleic Acids Research
|
April 8, 2022
Phosphorylated MED1 links transcription recycling and cancer growth
Zhong Chen, Zhenqing Ye, Raymond E Soccio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Epigenetics
|
May 5, 2011
Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
Kun-Tu Yeh, Tze-Ho Chen, Hui-Wen Yang, et al.
Cancer Immunology Research
|
March 8, 2017
Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers
Satish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.
Cancers
|
December 7, 2019
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer
Yen-Liang Liu, Aaron M Horning, Brandon Lieberman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2010
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou, Her-Young Su, Lin-Yu Chen, et al.
Cancer Research
|
August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer
Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.
Cancer Research
|
January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Josephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
Cell Reports
|
September 2, 2023
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
Chia-Nung Hung, Meizhen Chen, Daniel T DeArmond, et al.
Cancer Research
|
November 4, 2018
Adipokines Deregulate Cellular Communication via Epigenetic Repression of <i>Gap Junction</i> Loci in Obese Endometrial Cancer
Srikanth R Polusani, Yi-Wen Huang, Guangcun Huang, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
Nucleic Acids Research
|
April 8, 2022
Phosphorylated MED1 links transcription recycling and cancer growth
Zhong Chen, Zhenqing Ye, Raymond E Soccio, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Epigenetics
|
May 5, 2011
Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer
Kun-Tu Yeh, Tze-Ho Chen, Hui-Wen Yang, et al.
Cancer Immunology Research
|
March 8, 2017
Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers
Satish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.
Cancers
|
December 7, 2019
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer
Yen-Liang Liu, Aaron M Horning, Brandon Lieberman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2010
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou, Her-Young Su, Lin-Yu Chen, et al.
Cancer Research
|
August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer
Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.
Cancer Research
|
January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Josephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
Cell Reports
|
September 2, 2023
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
Chia-Nung Hung, Meizhen Chen, Daniel T DeArmond, et al.
Cancer Research
|
November 4, 2018
Adipokines Deregulate Cellular Communication via Epigenetic Repression of <i>Gap Junction</i> Loci in Obese Endometrial Cancer
Srikanth R Polusani, Yi-Wen Huang, Guangcun Huang, et al.
Page
of 17